Launch Accelerator
For Pfizer
Accelerate peak revenue and maximize brand launch success
Our EVP on Pfizer’s drug launches
Gaurav Kapoor
Executive Vice President, Indegene Inc.
We write to express our deep admiration for Pfizer's unwavering commitment to its vision of "Breakthroughs that change patients' lives." Your dedication to making a meaningful impact on patients and society mirrors the enduring values and purpose that drive Pfizer to excellence.
Pfizer's vision, as articulated, embodies a profound understanding of the vital role that purpose-driven companies play in today's dynamic healthcare landscape. Your emphasis on breakthroughs to change the lives of patients resonates powerfully and serves as an inspiration to all of us in the life sciences industry.
Our exclusive resource for Pfizer has been meticulously crafted to elucidate the critical importance of brand launch success, the common challenges brands encounter, and the precise strategies to maximize the success of these life-changing innovations. As a digital-first, life sciences commercialization company, we extend our heartfelt wishes for Pfizer's forthcoming launches to be marked by resounding success.
Hope we contribute to Pfizer's ambition to "Change a billion lives a year."
The importance and value of
launch brands are steadily rising
Importance of Launch brands
Future-ready companies are agile, resilient companies that are competitively positioned to make the most of the changes in the external environment by building scalable and sustainable capabilities to power innovation, maximize performance and drive growth.
More launches
per year
Greater percentage of
total sales
Between 2021-2028, 35% total drug sales are expected to come from drugs launched since 2021
Increasing sales potential
per launch
Future-ready companies are agile, resilient companies that are competitively positioned to make the most of the changes in the external environment by building scalable and sustainable capabilities to power innovation, maximize performance and drive growth.
But brands
struggle to
- Gain rapid critical market access coverage
- Unlock MLR approval bottlenecks
- Quickly engage and convert HCP awareness and trial
- Build HCP brand confidence with patient feedback
- Activate KOLs early to drive advocacy
- Improve time to market with creativity and data
Maximize brand launch success
with Launch Accelerator
- Accelerate payer engagement and activation
- Break through MLR bottlenecks at 2X-3X the speed
- Rapidly reach and convert more prescribers
- Cut weeks out of the RWE feedback loop from patient to prescriber
- Accelerate first prescription through digital KOL engagement
- Make the most of human creativity and artificial intelligence